PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Fraxinellone isolated from D. albus possesses excellent anti-hepatic fibrosis activity, though it suffers from poor oral bioavailability [PMID:34519225]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 26387739 (2015) — An ethnopharmacological and historical analysis of "Dictamnus", a European traditional herbal medicine. · Journal of ethnopharmacology
- 2.PMID: 35756457 (2022) — The complete chloroplast genome sequence of Dictamnus albus L. · Mitochondrial DNA. Part B, Resources
- 3.PMID: 17262448 (1989) — Flavonoids from Dictamnus albus. · Planta medica
- 4.PMID: 891175 (1977) — Phytophotodermatitis: an experimental study using the chamber method. · Contact dermatitis
- 5.PMID: 34519225 (2021) — Rational formulation engineering of fraxinellone utilizing 6-O-α-D-maltosyl-β-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy.